[12] [1] Scientific References Ozempic EPAR Product Information
Compare their efficacy, safety, duration of use, and cost
DPP-4 (not described in detail in this article) is the enzyme responsible for degrading native GLP-1 and GIP in the body
Thirteen states already cover the drugs under Medicaid programmes, despite the enormous up-front cost with others considering coverage
This protects developing hips and reduces the risk of hip dysplasia
But what some people dont understand is that when they stop taking the medication, they may gain all that weight back. (The current study did not evaluate weight gain after the discontinuation of GLP-1 medications.) GLP-1 medications act as a pharmaceutical version of a natural hormone in the gut, lowering blood sugar, keeping you feeling fuller longer and slowing down digestion